Trial · NCT04540094
Trial comparisons17
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 17 of 17
Download this page as JSON| Comparison | Source |
|---|---|
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Patients Developing Pulmonary Oedema | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Patients Who Receive Any Other Fluid Apart From Intervention or Control in First 6 Hrs After Recruitment | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Participants Needing Invasive Ventilation | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: 30-day Mortality | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Patients Developing Allergy or Anaphylaxis | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Recruitment Rate | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Patients Developing Acute Kidney Injury (AKI) | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Participants Needing Renal Replacement | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Patients Readmitted in First 90 Days After Discharge | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Number of Participants Needing Intravenous Vasopressors | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Proportion of Patients Admitted to Critical Care (HDU/ICU) | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: 90-day Mortality | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: deaths from any cause | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Data Completeness of Primary Outcome | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: In-hospital Mortality | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: Withdrawal From Study | Trial comparisons |
| 5% Human Albumin Solution vs Intravenous Balanced Crystalloid: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04540094/comparisons